Preclinical development of a cross-protective β-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59.
采用 MF59 佐剂的交叉保护性 β-SARS-CoV-2 病毒样颗粒疫苗的临床前开发。
期刊:NPJ Vaccines
影响因子:6.5
doi:10.1038/s41541-025-01355-y
Earnest Linda, Ruiz Daniel Fernandez, Edeling Melissa A, Montoya Julio Carrera, Yap Ashley Huey Yiing, Wong Chinn Yi, Holz Lauren E, Gras Stephanie, Collett Simon, Cooney James P, Davidson Kathryn C, Grimley Samantha L, Purcell Damian F J, Roberts Jason, Mumford Jamie, Tan Chee Wah, Wang Lin-Fa, Godfrey Dale I, Frieman Matthew, Hans Dhiraj, Vincan Elizabeth, Anderson Danielle E, Subbarao Kanta, Pellegrini Marc, Mackenzie Jason M, Rockman Steven, Heath William R, Torresi Joseph
